Amneal Pharmaceuticals Statistics
Total Valuation
AMRX has a market cap or net worth of $3.57 billion. The enterprise value is $6.05 billion.
| Market Cap | 3.57B |
| Enterprise Value | 6.05B |
Important Dates
The last earnings date was Thursday, October 30, 2025, before market open.
| Earnings Date | Oct 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AMRX has 314.08 million shares outstanding. The number of shares has increased by 9.44% in one year.
| Current Share Class | 314.08M |
| Shares Outstanding | 314.08M |
| Shares Change (YoY) | +9.44% |
| Shares Change (QoQ) | +0.74% |
| Owned by Insiders (%) | 39.22% |
| Owned by Institutions (%) | 46.71% |
| Float | 190.89M |
Valuation Ratios
The trailing PE ratio is 707.85 and the forward PE ratio is 13.45.
| PE Ratio | 707.85 |
| Forward PE | 13.45 |
| PS Ratio | 1.21 |
| Forward PS | 1.12 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 14.28 |
| P/OCF Ratio | 10.88 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.65, with an EV/FCF ratio of 24.23.
| EV / Earnings | 1,025.30 |
| EV / Sales | 2.06 |
| EV / EBITDA | 9.65 |
| EV / EBIT | 15.66 |
| EV / FCF | 24.23 |
Financial Position
The company has a current ratio of 2.13
| Current Ratio | 2.13 |
| Quick Ratio | 1.26 |
| Debt / Equity | n/a |
| Debt / EBITDA | 4.15 |
| Debt / FCF | 10.76 |
| Interest Coverage | 1.57 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 6.84% |
| Return on Invested Capital (ROIC) | 9.19% |
| Return on Capital Employed (ROCE) | 14.11% |
| Revenue Per Employee | $353,610 |
| Profits Per Employee | $711 |
| Employee Count | 8,300 |
| Asset Turnover | 0.83 |
| Inventory Turnover | 3.04 |
Taxes
In the past 12 months, AMRX has paid $11.04 million in taxes.
| Income Tax | 11.04M |
| Effective Tax Rate | 16.08% |
Stock Price Statistics
The stock price has increased by +33.69% in the last 52 weeks. The beta is 1.38, so AMRX's price volatility has been higher than the market average.
| Beta (5Y) | 1.38 |
| 52-Week Price Change | +33.69% |
| 50-Day Moving Average | 10.03 |
| 200-Day Moving Average | 8.57 |
| Relative Strength Index (RSI) | 69.07 |
| Average Volume (20 Days) | 1,554,224 |
Short Selling Information
The latest short interest is 5.75 million, so 1.83% of the outstanding shares have been sold short.
| Short Interest | 5.75M |
| Short Previous Month | 5.05M |
| Short % of Shares Out | 1.83% |
| Short % of Float | 3.01% |
| Short Ratio (days to cover) | 3.36 |
Income Statement
In the last 12 months, AMRX had revenue of $2.93 billion and earned $5.90 million in profits. Earnings per share was $0.02.
| Revenue | 2.93B |
| Gross Profit | 1.09B |
| Operating Income | 386.17M |
| Pretax Income | 68.66M |
| Net Income | 5.90M |
| EBITDA | 626.65M |
| EBIT | 386.17M |
| Earnings Per Share (EPS) | $0.02 |
Balance Sheet
The company has $201.25 million in cash and $2.69 billion in debt, giving a net cash position of -$2.48 billion or -$7.91 per share.
| Cash & Cash Equivalents | 201.25M |
| Total Debt | 2.69B |
| Net Cash | -2.48B |
| Net Cash Per Share | -$7.91 |
| Equity (Book Value) | -42.18M |
| Book Value Per Share | -0.35 |
| Working Capital | 976.37M |
Cash Flow
In the last 12 months, operating cash flow was $327.76 million and capital expenditures -$78.14 million, giving a free cash flow of $249.62 million.
| Operating Cash Flow | 327.76M |
| Capital Expenditures | -78.14M |
| Free Cash Flow | 249.62M |
| FCF Per Share | $0.79 |
Margins
Gross margin is 37.26%, with operating and profit margins of 13.16% and 0.20%.
| Gross Margin | 37.26% |
| Operating Margin | 13.16% |
| Pretax Margin | 2.34% |
| Profit Margin | 0.20% |
| EBITDA Margin | 21.35% |
| EBIT Margin | 13.16% |
| FCF Margin | 8.50% |
Dividends & Yields
AMRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.44% |
| Shareholder Yield | -9.44% |
| Earnings Yield | 0.17% |
| FCF Yield | 7.00% |
Analyst Forecast
The average price target for AMRX is $12.67, which is 11.34% higher than the current price. The consensus rating is "Buy".
| Price Target | $12.67 |
| Price Target Difference | 11.34% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |